Comparative, open-label prospective study on the quality of life and sexual function of women affected by endometriosis-associated pelvic pain on 2 mg dienogest/30 µg ethinyl estradiol continuous or 21/7 regimen oral contraceptive
Crossref DOI link: https://doi.org/10.1007/s40618-016-0460-6
Published Online: 2016-03-29
Published Print: 2016-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Caruso, S.
Iraci, M.
Cianci, S.
Fava, V.
Casella, E.
Cianci, A.
Text and Data Mining valid from 2016-03-29